HIV-NAT Thai Red Cross AIDS Research Center   Report issue

Foundation Phase 2 Phase 3 Phase 4
Founded: Bangkok Thailand (1996)

Organization Overview

First Clinical Trial
2003
NCT00476359
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

HIVNAT Bangkok | HIV-NAT, Bangkok, Thailand | HIV-NAT Program on AIDS - Thai Red Cross, Bangkok | HIV-NAT, Thai Red Cross AIDS Research Center | HIV-NAT, Thai Red Cross - AIDS Research Centre | HIV-NAT, The Thai Red Cross AIDS Research Centre

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acquired Immunodeficiency Syndrome (Phase 4)

Coinfection (Phase 4)

Communicable Diseases (Phase 4)

Fibrosis (Phase 3)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 4)

HIV Infections (Phase 4)

Infections (Phase 4)

Latent Tuberculosis (Phase 3)

Tuberculosis (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 17
  • # of Trial APIs: 23